US pharma firm reaffirms healthcare commitment in China
Huzur Devletsah, Lilly Group vice-president and China general manager. US pharmaceutical company Eli Lilly and Company has reaffirmed its strong commitment to advancing healthcare in China by participating in the China International Fair for Trade in Services (CIFTIS) for five consecutive years. Through this platform, the company showcases its cutting-edge products and strengthens clinical research…









